Core Facility Services supporting Bioscience Research When: October 9, 2026 at 9:00 am – 4:40 pm Where: Alhopuro auditorium, Kiinamyllynkatu 10, Medisiina D, Turku, 20520 Event Details The diversity of core facilities on the Turku campus supporting bioscience research has expanded in recent years. This event showcases the breadth of available services, and the role of European research infrastructures in

When: October 8, 2026, 12:00 am – 4:00 pm Where: Medisiina D, Kiinamyllynkatu 10, Turku, 20520 Event Details The Drug Discovery and Chemical Biology Platform coordinates infrastructure and expertise in the areas of drug discovery and chemical biology and makes it available to the scientific community. The DDCB platform provides services in assay development and chemical screening from medium to

The Biocenter Finland Bioinformatics platform invites you for a webinar series to introduce the various types of bioinformatics services offered by the platform. The webinar series aims to provide insight into the technology employed and a deeper understanding of the purpose of a given technology and how it is used in research. Topic: Building accessible tools for bioimage analysis Speaker: Guillaume Jacquemet is a

Biocenter Finland’s Director, Olli Silvennoinen, will conclude his term following its completion. We would like to express our warmest thanks to Olli for his dedicated and inspiring leadership during his tenure. It has been a pleasure to work with him. Under his guidance, collaboration between Finnish universities has been further strengthened and the activities of Biocenter Finland have continued to

The Finnish Electrophysiology Platform (FinE) organized its second national training course at Tampere University on 8–9 June 2026. The event attracted 65 participants from universities, research institutes, and industry across Finland and abroad, highlighting the growing interest in advanced electrophysiological methods and technologies. Participants of the FinE course in the lecture room on the second day of the course. Photo:

This year, BioCity Symposium is arranged on-site in Mauno Koivisto Centre, BioCity in 27–28 August 2026, with the title VISION, EXPANDED. Registration is open until Friday, 14 August 2026. Annual BioCity Symposium is a series of meetings organized since 1991 by BioCity Turku organization and it has become the most important annual get-together in the fields of biosciences and molecular

The Biocenter Finland Bioinformatics platform invites you for a webinar series to introduce the various types of bioinformatics services offered by the platform. The webinar series aims to provide insight into the technology employed and a deeper understanding of the purpose of a given technology and how it is used in research. Topic: Identifying driver genes for angiogenesis in the heart using

Session I: 3D Imaging and analysis in complex systems Session II: High-content drug screening & phenotypic discoveries in disease Session III: Cell Painting Assay Technology and Integrative Omics Registration link: https://www.lyyti.fi/reg/from_cells_to_systems_2026 Further inquiries: Vilja Pietiäinen, Adjunct Professor, PhD, Senior Scientist E-mail: vilja.pietiainen@helsinki.fi Mob.cell: +358-40-5102546 Institute for Molecular Medicine Finland FIMM Nordic EMBL Partnership for Molecular Medicine Biomedicum Helsinki 2U (D302b) P.O.Box 20 (Tukholmankatu 8) FI-00014 University of Helsinki, Finland

HELSINKI, Finland — Biocenter Finland is pleased to announce the appointment of Katja Kivinen as its new Director. Kivinen will begin her five-year term on April 1, 2026, succeeding Olli Silvennoinen, who will remain in his role until the end of June to ensure a seamless leadership transition. Kivinen joins Biocenter Finland from DeepScan Diagnostics, where she will continue to

FinE Course on Electrophysiology for In Vitro Models. Electrophysiology allows us to directly measure electrical activity in cells and tissues, providing functional insights that cannot be obtained through molecular or imaging-based approaches alone. As a core methodology in biomedical sciences, it has become increasingly important for research involving stem cell–derived disease models, organoids, organ-on-chip systems, and bioengineered tissues. BioCenter Finland

The Biocenter Finland Bioinformatics platform invites you for a webinar series to introduce the various types of bioinformatics services offered by the platform. The webinar series aims to provide insight into the technology employed and a deeper understanding of the purpose of a given technology and how it is used in research. The series will start off with presentations by the

The Finnish Proteomics Society warmly invites you to the upcoming 2026 Finnish Proteomics Symposium, taking place at Hotel Nuuksio in Espoo on March 12-13, 2026. This event brings together proteomics users and those interested in proteomics from Finland, the Nordic countries and beyond. We are proud to feature three distinguished keynote speakers who will share their cutting-edge research and innovative methods across

Biocenter Finland warmly thanks platforms, partner universities, industry partners, and other stakeholders for your collaboration and engagement during 2025. We wish you a peaceful holiday season and look forward to continuing our work together in 2026! Best wishes,Olli Silvennoinen, DirectorJenni Leppiniemi, CoordinatorEssi Erkkilä, Communications Specialist

The Biocenter Finland Bioinformatics platform invites you for a webinar series to introduce the various types of bioinformatics services offered by the platform. The webinar series aims to provide insight into the technology employed and a deeper understanding of the purpose of a given technology and how it is used in research. The series will start off with presentations by the

The FIMM High Throughput Biomedicine unit (FIMM-HTB) has recently purchased 12 new compound libraries that will be available soon. The new collection includes both large diversity libraries suitable for discovering novel bioactive molecules, and focused libraries containing approved drugs, known bioactives, and experimental compounds. These targeted sets are particularly useful for drug repurposing studies and for functional phenotyping, where they

At its winter meeting, EMBL (European Molecular Biology Laboratory) Council nominated Anthony A. Hyman as EMBL’s next Director General. Professor Hyman is currently director of the Max Planck Institute of Molecular Cell Biology and Genetics (MPI-CBG) in Dresden, Germany, and holds a Professorship of Molecular Biology at the Technische Universität Dresden. Hyman is known for his groundbreaking work on cell

Biocenter Finland invites applications for the position of Director (part-time) for the period 1.4.2026–30.6.2031. This leadership role provides a unique opportunity to influence the strategic direction and advancement of life science research infrastructures across Finland. About Biocenter Finland Biocenter Finland (BF) is a national organization, which develops and coordinates life science research infrastructures in Finland, including instruments, services, and databases.

The Biocenter Finland Bioinformatics platform invites you for a webinar series to introduce the various types of bioinformatics services offered by the platform. The webinar series aims to provide insight into the technology employed and a deeper understanding of the purpose of a given technology and how it is used in research. The series will start off with presentations by the node

The University of Eastern Finland (UEF) is inviting applications for a Project Researcher position in the Institute of Biomedicine, Kuopio campus. The position will be filled for a two-year term starting as soon as possible. Please, find more information below and submit your application by 03 November 2025. Role and salary  We are seeking a highly motivated and talented Bioinformatician

The Biocenter Finland Bioinformatics platform invites you for a webinar series to introduce the various types of bioinformatics services offered by the platform. The webinar series aims to provide insight into the technology employed and a deeper understanding of the purpose of a given technology and how it is used in research. The series will start off with presentations by the node